ScreenPoint Medical locks in $28m Series C

Netherlands-based ScreenPoint Medical, an AI technology company focused on early detection of breast cancer, has raised $28 million in Series C funding.

Netherlands-based ScreenPoint Medical, an AI technology company focused on early detection of breast cancer, has raised $28 million in Series C funding. Insight Partners led the round.

Source: Press Release